1Mo·

Vertex drop today

Hi everyone,

does anyone have any info on why $VRTX (+1,5 %) is going down the tubes today?

I couldn't find anything.

Thanks in advance :)

11 Commentaires

Marcel@xzxzx

1Mo

Poor Q figures

•

Marcel@Kytez

1Mo

@xzxzx oh crass, I have a great app for that, but I actually overlooked it 😂
Thank you 🙏🏼

••

Tenbagger2024@Tenbagger2024

1Mo

@Kytez
The figures were already there yesterday. That's why I'm surprised

••

Smudo@Smudeo

1Mo

The sharp decline came after the company announced its results for the first quarter of 2025 on Monday evening. Vertex reported first-quarter revenue of $2.77 billion, up 3% from the previous year. Adjusted earnings totaled $1.24 billion, or $4.76 per share, compared to $1.05 billion, or $4.06 per share, in the year-ago period. However, both revenue and earnings fell short of Wall Street consensus estimates. Vertex also announced that the portion of the Phase 1/2 trial evaluating its experimental messenger RNA (mRNA) therapy VX-522 for the treatment of cystic fibrosis (CF) with escalating multiple doses has been temporarily suspended. The company did not provide any details, stating only that there was a "tolerability issue".
@Kytez

•

Soprano@Soprano

1Mo

@Smudeo @TomTurboInvest I really don't want to be nasty, so don't hold it against me. Vertex is my absolute top favorite stock in the biotech sector, in which I myself am heavily invested - but once again the MRNA shot backfires. And this time I have to take the book losses myself.

•

TomTurboInvest@TomTurboInvest

1Mo

@Soprano I assume that you have included me here because of my $BNTX purchase. Scientific research has always been characterized by setbacks, but that doesn't stop me from continuing to support BioNTech 😅
If the level is right, I will continue to top up 🤷‍♂️

•

TomTurboInvest@TomTurboInvest

3Sem.

@Soprano take a look - there's something for you on mRNA https://youtu.be/YnrNADywr4E?si=A-Ydr42tLDd02ucf

•

Tenbagger2024@Tenbagger2024

3Sem.

@Soprano
Vertex doesn't just have one drug.
Vertex is a long runner and there is still a lot in the pipeline

•

Soprano@Soprano

3Sem.

@Tenbagger2024 They rely on several horses and technologies, including CRISPR

•

Tenbagger2024@Tenbagger2024

3Sem.

@Soprano
I don't understand why so many people rely on Novo or Merck, but Vertex is hardly ever mentioned

•

Soprano@Soprano

3Sem.

@Tenbagger2024 Vertex is still an insider's tip Most people don't actually know about Vertex because they mainly deal with rare diseases such as mucoviscidosis.

•